🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07717463
Recruiting Not applicable

Pericapsular Nerve Group Block Versus Femoral Nerve Block Study

NCT07717463 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-07-22
Last updated
2026-07-31

Condition(s) studied

Hip Fractures

Investigational drug(s) / intervention(s)

Ultrasound-Guided Pericapsular Nerve Group (PENG) BlockUltrasound-Guided Femoral Nerve BlockSpinal Anesthesia (bupivacaine)

Ultrasound-Guided Pericapsular Nerve Group (PENG) Block: Ultrasound-guided PENG block performed before spinal anesthesia using 20 mL of 0.25% bupivacaine to provide analgesia for patients undergoing surgery for proximal femur fracture.

Ultrasound-Guided Femoral Nerve Block: Ultrasound-guided femoral nerve block performed before spinal anesthesia using 20 mL of 0.25% bupivacaine to provide analgesia for patients undergoing surgery for proximal femur fracture.

Spinal Anesthesia (bupivacaine): Standard spinal anesthesia performed after the assigned peripheral nerve block using intrathecal hyperbaric bupivacaine according to the study protocol.

Study summary

Hip fractures are common in older adults and are often associated with severe pain, making it difficult for patients to sit for spinal anesthesia before surgery. Peripheral nerve blocks may improve pain control and facilitate patient positioning, but it remains uncertain whether the Pericapsular Nerve Group (PENG) block provides advantages over the traditional femoral nerve block during the spinal anesthesia procedure.

Eligibility

Sex
ALL
Min age
50 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adults aged 50 years or older. * Diagnosis of proximal femoral fracture. * Scheduled to undergo surgical repair under spinal anesthesia. * American Society of Anesthesiologists (ASA) physical status I-III. * Able to provide written informed consent. Exclusion Criteria: * Refusal to participate or inability to provide informed consent. * Coagulopathy or contraindication to spinal anesthesia or peripheral nerve block. * Local infection at the planned injection site. * Known allergy or hypersensitivity to local anesthetics. * Pre-existing neurological disease affecting lower extremity function or sensory assessment. * Cognitive impairment preventing reliable study participation or outcome assessment. * Previous lumbar spine surgery. * Polytrauma. * Body mass index (BMI) \<18 kg/m² or \>40 kg/m². * Current anticoagulant therapy that precludes neuraxial anesthesia or peripheral nerve block according to institutional practice.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Taksim Training and Research Hospital Istanbul Beyoglu Not Yet Recruiting
Taksim Training and Research Hospital Istanbul Turkey (Türkiye) Recruiting

More Taksim Egitim ve Arastirma Hastanesi trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07717463 on ClinicalTrials.gov ↗ ← All trials in Turkey